机构：[1]Zeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, MO, USA[2]Department of Neurology, Kasralainy school of Medicine, Cairo University, Cairo, Egypt[3]Zeenat Qureshi Stroke Institute, Department of Neurology, University of Firat, Elazig, Turkey[4]Department of Neurology, University of FIRAT, Elazig Turkey[5]Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran[6]Department of Neurosciences, Hospital Carlo Poma, ASST di Mantova, Mantua, Italy[7]Department of Neurology, University of Missouri, MO, USA[8]Stroke Center, Department of Neurology, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey[9]Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan[10]Department of Neurology, Creighton University Medical Center/CHI Health, Omaha, NE, USA[11]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China神经科系统神经外科介入放射科[12]Department of Neurology and Interventional Stroke Treatment Centre, Kazimierz Pulaski University of Technology and Humanities, Radom, Poland[13]Department of Neurology, Yeungnam University School of Medicine, Daegu, Korea[14]Pakistan Emirates Military Hospital (J.L.), Rawalpindi, Pakistan[15]Department of Interventional Neuroradiology, Rothschild Foundation Hospital, University of Paris, Laboratory of Vascular Translational Sciences, Paris, France[16]Stroke & Neurointervention Artemis Hospitals, Gurugram, India[17]Department of Neurology, Klinikum Frankfurt Ho¨chst, Frankfurt and Heidelberg University Hospital, Heidelberg, Germany[18]St Cloud Hospital, St Cloud, MN, USA[19]Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan[20]Department of Neurology, Hospital Vall d’Hebron, Universitat Autonoma de Barcelona, Spain[21]Servicio de Neurologı´a, Hospital Universitario Jose´ Eleuterio Gonza´lez de la Universidad Auto´noma de Nuevo Leo´n, Monterrey, Nuevo Leo´n, Me´xico[22]Instituto de Neurologı´a y Neurocirugı´a, Hospital Zambrano Hellion, Tecnolo´gico de Monterrey, San Pedro, Nuevo Leo´n, Me´xico[22]Department of Biomorphology, Federal University of Bahia, Salvador, Brazil[23]Beverly Hills Pain Institute and Neurology, Beverly Hills, CA, USA[24]Tiantan Comprehensive Stroke Center, Beijing Tiantan Hospital, Capital Medical University Beijing, China首都医科大学附属天坛医院
On 11 March 2020, World Health Organization (WHO) declared the COVID-19 infection a pandemic. The risk of ischemic stroke may be higher in patients with COVID-19 infection similar to those with other respiratory tract infections. We present a comprehensive set of practice implications in a single document for clinicians caring for adult patients with acute ischemic stroke with confirmed or suspected COVID-19 infection.
The practice implications were prepared after review of data to reach the consensus among stroke experts from 18 countries. The writers used systematic literature reviews, reference to previously published stroke guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and when appropriate, formulate practice implications. All members of the writing group had opportunities to comment in writing on the practice implications and approved the final version of this document.
This document with consensus is divided into 18 sections. A total of 41 conclusions and practice implications have been developed. The document includes practice implications for evaluation of stroke patients with caution for stroke team members to avoid COVID-19 exposure, during clinical evaluation and performance of imaging and laboratory procedures with special considerations of intravenous thrombolysis and mechanical thrombectomy in stroke patients with suspected or confirmed COVID-19 infection.
These practice implications with consensus based on the currently available evidence aim to guide clinicians caring for adult patients with acute ischemic stroke who are suspected of, or confirmed, with COVID-19 infection. Under certain circumstances, however, only limited evidence is available to support these practice implications, suggesting an urgent need for establishing procedures for the management of stroke patients with suspected or confirmed COVID-19 infection.
第一作者机构：[1]Zeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, MO, USA
通讯作者：
通讯机构：[*1]Department of Neurology, Creighton University School of Medicine Immanuel Medical Center, 6901 N 72 St., Suite 5300, Omaha, NE 68122, USA[10]Department of Neurology, Creighton University Medical Center/CHI Health, Omaha, NE, USA
推荐引用方式(GB/T 7714)：
Adnan I Qureshi,Foad Abd-Allah,Fahmi Alsenani,et al.Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel.[J].INTERNATIONAL JOURNAL OF STROKE.2020,15(5):540-554.doi:10.1177/1747493020923234.
APA：
Adnan I Qureshi,Foad Abd-Allah,Fahmi Alsenani,Emrah Aytac,Afshin Borhani-Haghighi...&Yongjun Wang.(2020).Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel..INTERNATIONAL JOURNAL OF STROKE,15,(5)
MLA：
Adnan I Qureshi,et al."Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel.".INTERNATIONAL JOURNAL OF STROKE 15..5(2020):540-554
